Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $90.8900 (2.3%) ($90.8900 - $90.9700) on Fri. Jul. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.55% (three month average) | RSI | 66 | Latest Price | $90.8900(2.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.4% a day on average for past five trading days. | Weekly Trend | LGND advances 7.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(51%) IWM(51%) IWO(51%) IWC(49%) IWN(49%) | Factors Impacting LGND price | LGND will decline at least -1.775% in a week (0% probabilities). UUP(-16%) VXX(-15%) VIXM(-10%) UNG(-8%) TBT(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.775% (StdDev 3.55%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $88.93(2.2%) | 10 Day Moving Average | $86.25(5.38%) | 20 Day Moving Average | $83.28(9.14%) | To recent high | -22.1% | To recent low | 22.1% | Market Cap | $1.461b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |